Yarrowbioscience
1 known investors
Find your way into Yarrowbioscience
Sign up to see every warm intro you have to Yarrowbioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Yarrowbioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Yarrow Bioscience develops a first-in-class anti-TSHR antibody to treat thyroid autoimmune diseases, specifically Graves' disease and thyroid eye disease. It operates in the biotech and therapeutics space.
Investors · 1
Frequently asked questions
- What does Yarrowbioscience do?
- Yarrow Bioscience develops a first-in-class anti-TSHR antibody to treat thyroid autoimmune diseases, specifically Graves' disease and thyroid eye disease. It operates in the biotech and therapeutics space.
- Who are Yarrowbioscience's investors?
- Yarrowbioscience's investors include OrbiMed.
